Nufarm - Public Comps and Valuation Multiples

Nufarm Overview

About Nufarm

Nufarm Limited is a global crop-protection company that develops, manufactures, and sells a range of crop-protection products, including herbicides, insecticides, and fungicides. Nufarm sells its products in most of the world's major agricultural regions, and operates primarily in the off-patent segment of the crop-protection market. Nufarm operates along two business lines: crop protection and seed technologies.

Founded

2000

HQ

Employees

3.1K+

Website

nufarm.com

Sectors

Agriculture

Financials

LTM Revenue $2.3B

LTM EBITDA $195M

EV

$1.5B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Nufarm Financials

As of August 2025, Nufarm reported last 12-month revenue of $2.3B and EBITDA of $195M.

In the same period, Nufarm generated $233M in LTM gross profit and -$8.3M in net income.

See Nufarm valuation multiples based on analyst estimates

Nufarm P&L

In the most recent fiscal year, Nufarm reported revenue of $2.2B and EBITDA of $173M.

Nufarm expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Nufarm valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$2.3B	XXX	$2.2B	XXX	XXX	XXX
Gross Profit	$233M	XXX	$551M	XXX	XXX	XXX
Gross Margin	10%	XXX	25%	XXX	XXX	XXX
EBITDA	$195M	XXX	$173M	XXX	XXX	XXX
EBITDA Margin	9%	XXX	8%	XXX	XXX	XXX
EBIT	$54.1M	XXX	-$114M	XXX	XXX	XXX
EBIT Margin	2%	XXX	-5%	XXX	XXX	XXX
Net Profit	-$8.3M	XXX	-$3.7M	XXX	XXX	XXX
Net Margin	0%	XXX	0%	XXX	XXX	XXX
Net Debt	XXX	XXX	$320M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Nufarm including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $2.3B. EBITDA for the last twelve months was $195M. In the most recent fiscal year, Nufarm achieved $2.2B in revenue and $173M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$2.3B	Analyst estimates available to subscribers	$2.2B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$233M	Analyst estimates available to subscribers	$551M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	10.2% gross margin	Analyst estimates available to subscribers	25.1% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$195M	Analyst estimates available to subscribers	$173M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	8.6% EBITDA margin	Analyst estimates available to subscribers	7.9% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$54.1M	Analyst estimates available to subscribers	-$114M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	2.4% EBIT margin	Analyst estimates available to subscribers	-5.2% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$8.3M	Analyst estimates available to subscribers	-$3.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-0.4% net profit margin	Analyst estimates available to subscribers	-0.2% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$320M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Nufarm

This financial data table provides comprehensive performance metrics for Nufarm, a company based in Australia. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Nufarm generated $2.3B in revenue over the last twelve months.
The company achieved $195M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $233M.
Net income over the last twelve months reached -$8.3M.

Fiscal Year Performance

In the most recent fiscal year, Nufarm reported $2.2B in total revenue.
Fiscal year EBITDA was $173M.
The company maintained a gross profit margin of 25.1% in the most recent fiscal year.
EBITDA margin for the fiscal year was 7.9%.
Net profit margin reached -0.2% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Nufarm. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Nufarm Stock Performance

Nufarm has current market cap of AUD 915M (or $600M), and EV of AUD 2.3B (or $1.5B).

Market Cap Evolution

Nufarm Stock Data

As of September 17, 2025, Nufarm's stock price is AUD 2 (or $2).

See Nufarm trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.5B	$600M	XXX	XXX	XXX	XXX	$-0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Nufarm Valuation Multiples

Nufarm's trades at 0.7x EV/Revenue multiple, and 8.4x EV/EBITDA.

See valuation multiples for Nufarm and 15K+ public comps

Nufarm Financial Valuation Multiples

As of September 17, 2025, Nufarm has market cap of $600M and EV of $1.5B.

Equity research analysts estimate Nufarm's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Nufarm has a P/E ratio of -72.6x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$600M	XXX	$600M	XXX	XXX	XXX
EV (current)	$1.5B	XXX	$1.5B	XXX	XXX	XXX
EV/Revenue	0.7x	XXX	0.7x	XXX	XXX	XXX
EV/EBITDA	7.6x	XXX	8.4x	XXX	XXX	XXX
EV/EBIT	27.6x	XXX	-20.6x	XXX	XXX	XXX
EV/Gross Profit	6.4x	XXX	n/a	XXX	XXX	XXX
P/E	-72.6x	XXX	-123.2x	XXX	XXX	XXX
EV/FCF	-9.4x	XXX	23.0x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Nufarm Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Nufarm Margins & Growth Rates

Nufarm's last 12 month revenue growth is 6%

Nufarm's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.2M for the same period.

Nufarm's rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Nufarm's rule of X is 23% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Nufarm and other 15K+ public comps

Nufarm Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	6%	XXX	5%	XXX	XXX	XXX
EBITDA Margin	9%	XXX	8%	XXX	XXX	XXX
EBITDA Growth	28%	XXX	-9%	XXX	XXX	XXX
Rule of 40	17%	XXX	14%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	23%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.7M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	16%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	2%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	30%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial